Serine protease inhibitors--N-substituted derivatives
US6001811A · kind A · utility
8Cited by
6References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 1997 |
| Grant date | Dec 14, 1999 |
| Priority date | — |
| Expiry date | Dec 4, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to oxadiazole, thiadiazole, and triazole peptoids that are inhibitors of serine protease, specifically human neutrophil elastase; which proteases are useful in treatment of adult respiratory distress syndrome, septic shock, and multiple organ failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.